Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating environmental and clinical surveillance for typhoid: insights from a prospective wastewater surveillance study in urban India.

The Lancet. Microbe·2026
Same author

The productivity losses due to cancer mortality and morbidity in 13 Asia-Pacific geographies across 2010, 2015, 2019, and 2022.

Journal of medical economics·2026
Same author

Quantifying the role of contact sampling for poliovirus detection in Nigeria.

PLOS global public health·2026
Same author

Estimating the nationwide incidence of coxsackievirus A6-associated hand, foot and mouth disease in China, 2008-2022.

Infectious diseases of poverty·2026
Same author

Integration of poliovirus and enteropathogen sewage surveillance in Dhaka Bangladesh: a longitudinal surveillance study, June 2019-June 2020.

The Lancet. Microbe·2026
Same author

Searching for immune correlates in Lassa vaccine development - workshop report.

NPJ vaccines·2026

Related Experiment Video

Updated: Jun 10, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Modelling trachoma for control programmes.

Manoj Gambhir1, María-Gloria Basáñez, Isobel M Blake

  • 1Department of Infectious Disease Epidemiology, Faculty of Medicine, St. Mary's campus, Imperial College London, Norfolk Place, London W2 1PG, UK. m.gambhir@imperial.ac.uk

Advances in Experimental Medicine and Biology
|July 17, 2010
PubMed
Summary
This summary is machine-generated.

A new mathematical model predicts how trachoma control programs impact Chlamydia trachomatis infections and blindness. This model accounts for repeated infections causing scarring, aiding treatment effectiveness evaluation.

More Related Videos

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Related Experiment Videos

Last Updated: Jun 10, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Mathematical Biology

Background:

  • Trachoma is a leading cause of preventable blindness globally, affecting 63 million individuals.
  • Control programs focus on eliminating ocular Chlamydia trachomatis and improving sanitation to curb transmission.
  • Antibiotic treatment effectiveness is under scrutiny for managing this widespread infection.

Purpose of the Study:

  • To develop a mathematical model for predicting the impact of trachoma control interventions.
  • To incorporate the pathogenesis of trachoma, including scarring from repeated infections, into the model.
  • To dynamically assess the effects of treatment on infection and disease sequelae.

Main Methods:

  • Development of a novel mathematical model simulating trachoma infection dynamics.
  • Inclusion of age- and time-dependent epidemiological patterns observed in endemic areas.
  • Modeling the long-term consequences of repeated infection cycles leading to scarring.

Main Results:

  • The model accurately reproduces observed epidemiological patterns of trachoma.
  • It allows for the prediction of infection prevalence and disease progression over time.
  • The model enables the evaluation of treatment strategies on infection and sequelae.

Conclusions:

  • The developed mathematical model is a valuable tool for understanding trachoma epidemiology.
  • It aids in predicting the long-term impact of control programs and treatment interventions.
  • This approach can guide public health strategies to reduce trachoma-related blindness.